Softgel Capsules Market Summary

The global softgel capsules market size was estimated at USD 7.67 billion in 2022 and is projected to reach USD 13.09 billion by 2030, growing at a CAGR of 6.9% from 2023 to 2030. The increasing demand for softgel capsules is primarily driven by their superior characteristics, such as ease of swallowing, effective masking of unpleasant odor and taste, enhanced absorption, improved bioavailability, and exceptional atmospheric stability. These benefits make softgel capsules a preferred dosage form across pharmaceuticals, nutraceuticals, and dietary supplements industries.

Continuous advancements in capsule manufacturing technology and the development of innovative materials have led to the evolution of traditional capsules, enhancing their efficiency and functionality. Modern softgel capsules now offer advanced features such as controlled drug release, tamper-evident properties, and the ability to accommodate potent active pharmaceutical ingredients (APIs). These innovations are attributed to better resistance against stomach acid degradation, visually appealing designs, and extended product shelf life. Such technological improvements have broadened the scope of capsule-based formulations, contributing to the rising adoption of softgel capsules in various therapeutic and nutritional applications.

Key Market Trends & Insights

• North America dominated the global market, accounting for the largest revenue share of 42.3% in 2022. The region’s strong presence is supported by a well-established pharmaceutical and nutraceutical industry, high consumer awareness regarding health supplements, and a growing preference for easily consumable dosage forms.
• Asia Pacific is projected to expand at the fastest CAGR of 8.6% during the forecast period. Rapid industrialization in the pharmaceutical and nutraceutical sectors, increasing healthcare expenditure, and rising health awareness among consumers in emerging economies such as China and India are key factors contributing to regional market growth.
• Based on type, the gelatin-based or animal-based segment led the market with the largest revenue share in 2022. This dominance can be attributed to the widespread use of gelatin for its cost-effectiveness, high strength, flexibility, and compatibility with various pharmaceutical formulations.
• In terms of application, the vitamins and dietary supplements segment held the largest revenue share in 2022. The rising focus on preventive healthcare, growing geriatric population, and increasing use of nutritional supplements to address vitamin deficiencies have significantly driven segment growth.
• Based on end use, the nutraceutical companies segment dominated the market, accounting for a revenue share of 37.7% in 2022. The growing trend of self-medication, coupled with the increasing popularity of over-the-counter nutritional supplements, has contributed to the segment’s expansion.

Order a free sample PDF of the Softgel Capsules Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2022 Market Size: USD 7.67 Billion
• 2030 Projected Market Size: USD 13.09 Billion
• CAGR (2023-2030): 6.9%
• North America: Largest market in 2022
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

The rise in competition is leading to rapid technological advancements and companies are constantly working towards the improvement of their products, with a major focus on research and development. Factors such as investment in R&D, compliance with regulatory policies, and technological advancements are constantly driving the introduction of novel techniques. Outsourcing of softgel capsules is the leading trend adopted by large manufacturers, reducing their burden of equipment expenditure, and ensuring a competitive sales price to adhere in the competitive market.

Research to develop capsule in capsules, tablets in capsules, and controlled release medication for critical drugs, is undertaken by market leaders to strengthen their product portfolio and maintain market position. Manufacturers are focusing on consolidating their position by strengthening their manufacturing capabilities. For instance, in January 2023, Sirio Pharma announced the acquisition of Best Formulations, a manufacturer of plant-based softgels, gummies, etc. This acquisition is expected to expand the production capacity, product portfolio, and research and development capabilities of Sirio Pharma.

Similarly, in April 2022, Catalent announced the acquisition of a biologics development and manufacturing facility from Vaccine Manufacturing and Innovation Centre UK Limited (VMIC Ltd.). The facility, presently under construction near Oxford, UK, will bolster Catalent's capabilities in the field of biologics.Catalent has outlined its strategic plan to invest up to USD 160 million to finalize the construction and equip the facility with cutting-edge capabilities. This investment will enable the facility to undertake the development and manufacturing of biologic therapies and vaccines, encompassing a range of advanced modalities such as mRNA, proteins, and other innovative technologies. 

Key Players

• Fuji Capsule
• Sirio Pharma Co., Ltd.
• CAPTEK Softgel International Inc.
• Thermo Fisher Scientific Inc.
• EyePoint Pharmaceuticals, Inc.
• Catalent, Inc.
• EuroCaps
• Aenova Group
• Lonza Capsules & Health Ingredients
• ProCaps Laboratories, LLC
• Soft Gel Technologies, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global softgel capsules market is expected to maintain steady growth over the forecast period, driven by increasing consumer preference for convenient, efficient, and aesthetically appealing dosage forms. Ongoing advancements in capsule formulation technologies and material innovation will continue to expand the product’s applications across pharmaceutical and nutraceutical industries. With rising health awareness, an aging population, and the growing use of dietary supplements, the demand for softgel capsules is set to strengthen further, positioning them as a key component in the future of oral drug and supplement delivery systems.